Universitätsmedizin Berlin, the research network involves all 36 German university hospitals and partners on working on solutions for the best possible health care and pandemic preparedness. Emphasis is
professional services to academic researchers in case of MHH trial sponsorship and also to industry partners and can draw on many years of professional experience. Founded in 2005, the Hannover Clinical Trial
by Professor Hartmann from Neuropathology and Professor Krauss from Neurosurgery, as well as with partners from the University Medical Center Göttingen (UMG), are now demonstrating a new mechanism that improves
23rd, 2007. In this building, which is to be finished in summer 2008, those scientists and further partner institutes will be accommodated, who last year for the project REBIRTH ("From regenerative Biology
Hannover, Würzburg, Heidelberg, Göttingen and Munich are co-coordinators. Additional implementation partners are Berlin, Dresden, Essen, Freiburg, Mainz, Münster, Ulm, and Cottbus.
- Research Center for Translational Regenerative Medicine'. In addition to the MHH, seven other partners are involved: the Leibniz Universität Hannover, the Laser Zentrum Hannover e.V., the Stiftung T
including rejection reactions. In addition, our scientific interest in cooperation with clinical partners of the MHH and other university hospitals also applies to immunosuppression after organ transplantation
Region Hannover" (Hanover Region Researchers' Kids Network), the Hanover Region is a cooperation partner of the foundation, organizes the training courses, finances the personnel and material costs and
years. As part of the call for “ Translationsprojekte Personalisierte Medizin ”, the consortium partners, led by Prof. Dr. Ulrich Martin, are pursuing the goal that their approach should offer in future [...] supported by a Left Ventricular Assist Device (LVAD) as a bridge-to-repair strategy. Consortial partners The project is coordinated by Prof. Dr. Ulrich Martin (Leibniz Research Laboratories for Biotechnology
to disturbed communications between immune cells and endothelium. Therefore, together with DZIF partners in Munich (TUM, LMU), Heidelberg, Marburg, Tübingen and Hamburg (UKE), we are investigating important